Analytics
Yes is at 44%, down 5.5 points from 49.5% when the market opened on 24 Jun 2026.
Across the 126 daily closes on record from 24 Jun 2026 to 30 Oct 2026 (4 days in that span have no close), the highest close was 75.5% on 22 Jul 2026 and the lowest 28.5% on 15 Jul 2026. A week before that last close Yes was at 51%; a month before, 49.5%. Its largest one-day move was 25 points down, to 35% on 30 Jun 2026.
$30 traded in the last 24 hours, out of $2.85K since listing. The order book holds $143.39, with a 54.0% gap between the best bid and the best ask. Across the latest 87 trades, $214.36 bought Yes and $493.78 bought No.
The largest Yes position is zhyfacai with 154 shares; the largest No position is Emerald Orbit AC64 with 94. Ten wallets hold 93.2% of the shares on Polymarket's public holder list.
Trading closes on 1 Jan 2027, 63 days from now.
Polymarket prices as of Oct 30, 4:37 PM UTC
Daily closes of the Yes price, Polymarket CLOB, 126 points, 24 Jun 2026 – 30 Oct 2026
| Observed | Yes price |
|---|---|
| 24 Jun 2026 | 49.5% |
| 30 Oct 2026 | 44.0% |
The ten largest positions on Polymarket's public holder list.
| Trader | Outcome | Shares |
|---|---|---|
| zhyfacai | Yes | 154 |
| Emerald Orbit AC64 | No | 94.44 |
| wallet-account-test | No | 80 |
This market will resolve to “Yes” if the Food and Drug Administration (FDA) announces that it has reclassified or will reclassify BPC-157 to Category 1 of the Bulk Drug Substances List by the listed date, 11:59 PM ET. Otherwise, this market will resolve to “No”. A qualifying announcement must be official and public. Any rumored or private statements of intention will not qualify. Any announcement that the drug has been reclassified to Category 1 will qualify. Any announcement within this market’s timeframe of future intention to reclassify to Category 1 will qualify regardless of whether the reclassification has happened by the listed date. A qualifying reclassification must be to Category 1 of the Bulk Drug Substances List or an equivalent classification that allows interim compounding of the drug. Removal from a different category will not qualify. The resolution source for this market will be official statements from the FDA; however, a consensus of credible reporting will also be used.
Official listing: polymarket.com/event/fda-moves-bpc-157-to-category-1-by-20260622202229566
| dropmeplease |
| Yes |
| 60 |
| pd.unique | Yes | 42.58 |
| fsfsdfbot | No | 20 |
| Slackjaw | No | 19.99 |
| Hakei. | Yes | 16 |
| WifesDoubleDTrust | No | 15 |
| Squiggly-Description | No | 13.12 |
Open a trader’s name to inspect the wallet’s available P&L, positions and recorded trades, with source dates and coverage. A large position alone does not establish a winning track record.
New to prediction markets? How to read a market page
